Original from: Agilent
Highlights
· Revenue of $1.74 billion for the third quarter ended July 31, 2025, exceeding revenue guidance and representing growth of 10.1% reported and up 6.1% on a core basis compared with the third quarter of 2024.
· GAAP net income of $336 million; earnings per share (EPS) of $1.18, up 22% from the third quarter of 2024.
· Non-GAAP net income of $390 million; EPS of $1.37, up 4% from the third quarter of 2024.
· These results reflect a full quarter of the dynamic tariff environment.
Outlook for full 2025 fiscal year and Q4
· Full-year revenue outlook revised at a range of $6.91 billion to $6.93 billion, representing a range of up 6.2% to 6.5% reported and up 4.3% to 4.6% core. Non-GAAP EPS is expected in the range of $5.56 to $5.59.
· Q4 revenue outlook is expected to be in the range of $1.822 billion to $1.842 billion, an increase of 7.1% to 8.3% reported and up 4.8% to 6.0% core. Non-GAAP EPS expected in the range of $1.57 to $1.60 per share.
Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.74 billion for the third quarter ended July 31, 2025, exceeding revenue guidance and representing growth of 10.1% reported and up 6.1% core(1) compared with the third quarter of 2024.
Third-quarter GAAP net income was $336 million, or $1.18 per share. This compares with $282 million, or $0.97 per share, in the third quarter of 2024. Non-GAAP net income was $390 million, or $1.37 per share during the quarter, compared with $385 million or $1.32 per share during the year-ago quarter.
"Our third-quarter performance, which marks our fifth consecutive quarter of sequential core-revenue acceleration, is a testament to the success of our Ignite Transformation and our laser-like focus on profitable growth and operational excellence," said Agilent President and CEO Padraig McDonnell. "All three of our business groups grew, along with all regions and our two largest markets. Our Ignite enterprise operating model enables us to nimbly and quickly navigate a highly dynamic macro environment while remaining focused on our strong execution, innovation pipeline, and deep customer relationships."
Financial Highlights
In the first quarter of 2025, Agilent implemented certain changes to its segment reporting structure. Prior-period segment information has been recast to reflect these changes. These changes have no impact on Agilent's consolidated financial statements.
Life Sciences and Diagnostics Markets Group
The Life Sciences and Diagnostics Markets Group (LDG) reported third-quarter revenue of $670 million, an increase of 14% reported and 7% core year-over-year. LDG's operating margin for the quarter was 17.6%.
Agilent CrossLab Group
The Agilent CrossLab Group (ACG) reported third-quarter revenue of $744 million, an increase of 8% reported and 5% core year-over-year. ACG's operating margin for the quarter was 33.3%.
Applied Markets Group
The Applied Markets Group (AMG) reported third-quarter revenue of $324 million, an increase of 7% reported and 5% core year-over-year. AMG's operating margin for the quarter was 21.8%.
Full Year 2025 and Q4 Outlook
Full-year revenue outlook is now in the range of $6.91 billion to $6.93 billion, representing growth of 6.2% to 6.5% reported and up 4.3% to 4.6% core. Non-GAAP EPS is expected in the range of $5.56 to $5.59 per share.
The outlook for fourth-quarter revenue is expected to be in the range of $1.822 billion to $1.842 billion, representing growth of 7.1% to 8.3% reported and up 4.8% to 6.0% core. Non-GAAP EPS is expected in the range of $1.57 to $1.60 per share.
The outlook is based on forecasted currency exchange rates.
Source: Agilent Reports Third-Quarter Fiscal Year 2025 Financial Results
Copyright © 2025 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )
We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News.
sign-up for our newsletter today.
To ensure our newsletter hit your inbox, make sure to add @caclp.com to your safe senders list. And, as always, feel free to contact
us with any questions and thanks again for subscribing.